CIBC Private Wealth Group
TAK icon

CIBC Private Wealth Group’s Takeda Pharmaceutical TAK Stock Holding History

CIBC Private Wealth Group’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$5.52K Sell
354
-655
-65% -$9.37K ﹤0.01% 2599
2025
Q3 		$14.8K Buy
1,009
+307
+44% +$4.56K ﹤0.01% 2254
2025
Q2 		$10.9K Sell
702
-35
-5% -$517 ﹤0.01% 2222
2025
Q1 		$10.4K Buy
737
+558
+312% +$7.82K ﹤0.01% 2236
2024
Q4 		$2.37K Sell
179
-96
-35% -$1.32K ﹤0.01% 2667
2024
Q3 		$3.92K Sell
275
-50
-15% -$709 ﹤0.01% 2658
2024
Q2 		$4.28K Buy
325
+147
+83% +$1.95K ﹤0.01% 2557
2024
Q1 		$2.43K Buy
+178
New +$2.59K ﹤0.01% 2706
2019
Q2 		– Sell
-10,852
Closed -$221K – 954
2019
Q1 		$221K Buy
+10,852
New +$218K ﹤0.01% 883

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CIBC Private Wealth Group's TAK Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Takeda Pharmaceutical (TAK) stake by 65% in Q4 2025, selling an estimated $9.37K and leaving 354 shares worth $5.52K. The position accounts for ﹤0.01% of the portfolio, ranked #2599.

CIBC Private Wealth Group first reported a position in TAK in Q1 2019 and has held it in 9 quarters since. The position peaked at $221K in Q1 2019. 349 funds tracked by Wall St. Rank hold TAK as of Q4 2025.

  • CIBC Private Wealth Group held 354 shares of Takeda Pharmaceutical worth $5.52K as of Q4 2025.
  • CIBC Private Wealth Group sold 655 Takeda Pharmaceutical shares in Q4 2025, an estimated $9.37K.
  • Takeda Pharmaceutical made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2599 holding.
  • CIBC Private Wealth Group first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 9 quarters since.
  • CIBC Private Wealth Group's Takeda Pharmaceutical position peaked at $221K in Q1 2019.
  • 349 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.